# Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

> **NCT00687011** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 118 (actual)

## Conditions studied

- Neoplasms
- Nausea
- Vomiting

## Interventions

- **DRUG:** Palonosetron and Dexamethasone

## Key facts

- **NCT ID:** NCT00687011
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-10
- **Primary completion:** 2008-10-27
- **Final completion:** 2008-10-27
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687011, "Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00687011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*